Recordati Industria Chimica e Farmaceutica SpA
F:RER1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Recordati Industria Chimica e Farmaceutica SpA
F:RER1
|
IT |
|
T
|
Telefonaktiebolaget LM Ericsson
F:ERCB
|
SE |
|
E
|
Ecolab Inc
XMUN:ECJ
|
US |
Wall St Price Targets
RER1 Price Targets Summary
Recordati Industria Chimica e Farmaceutica SpA
According to Wall Street analysts, the average 1-year price target for RER1 is 61.26 EUR with a low forecast of 50.08 EUR and a high forecast of 77.01 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RER1's stock price target?
Price Target
61.26
EUR
According to Wall Street analysts, the average 1-year price target for RER1 is 61.26 EUR with a low forecast of 50.08 EUR and a high forecast of 77.01 EUR.
What is the Revenue forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 6%.
What is the Operating Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is 9%.
What is the Net Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 14%.
